Loading viewer...
investor_presentation
Format: PDF investor_presentation
Third quarter and first nine months 2017 Results Release October 19th, 2017
Third quarter and first nine months 2017
October 19th, 20172 ©2017 SAP SE or an SAP affiliate company. All rights reserved.Safe harbor statement
Any statements contained in this document that are not historical facts are forward -looking
statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such
as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,”
“predict,” “should” and “will” and similar expressions as they relate to SAP are intended to
identify such forward -looking statements. SAP undertakes no obligation to publicly update or
revise any forward -looking statements. All forward -looking statements are subject to various
risks and uncertainties that could cause actual results to differ materially from expectations. The
factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings
with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual
Report on Form 20 -F filed with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward -looking statements, which speak only as of their
dates. Income Statement
Balance Sheet and Cash Flow Analysis
Outlook and Additional Information
Appendix4 ©2017 SAP SE or an SAP affiliate company. All rights reserved.Key performance metrics Q3 2017
Cloud Subscriptions &
in €millionsTotal Revenue
in €millionsShare of
in percent4,455 4,4564,657 4,658
IFRS Non-IFRSCloud & Software Revenue
+5% (+8% cc) +5%1,1031,638
IFRS Non-IFRSOperating Profit
+1p.p.5 ©2017 SAP SE or an SAP affiliate company. All rights reserved.Key performance metrics 9M 2017
Cloud Subscriptions &
in €millionsTotal Revenue
in €millionsShare of
in percent12,663 12,66813,742 13,743
IFRS Non-IFRSCloud & Software Revenue
Preview truncated — download the full document for the complete content.
earnings
28 Pages
investor_presentation
24 Pages
Verano Holdings Corp.
investor_presentation
PAVmed
Xenon Pharmaceuticals Investor Presentation — May 2022
investor_presentationinvestor_presentation
19 Pages
Xenon Pharmaceuticals Inc.
Healthcare Triangle 2022 Investor Presentation
investor_presentationinvestor_presentation
25 Pages
Healthcare Triangle, Inc.